Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

A. Shepherd, Frances; Rodrigues Pereira, José; Ciuleanu, Tudor–Eliade; Huat Tan, Eng; Hirsh, Vera; Thongprasert, Sumitra; Campos, Daniel; Maoleekoonpiroj, Savitree; Smylie, Michael; Martins, Renato; Van Kooten, Maximiliano; Dediu, Mircea; Findlay, B.; Tu, Dongsheng; Johnston, D.; Bezjak, Andrea; M. Clark, Gary; Santabárbara, P.; Seymour, Lesley

doi:10.1056/nejmoa050753

Public

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Published in New England Journal of Medicine • Jul 13, 2005

Authors:

Frances A. Shepherd

José Rodrigues Pereira

Tudor–Eliade Ciuleanu

Abstract

BACKGROUND: We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line chemotherapy. METHODS: Patients with stage IIIB o...

Subject

Erlotinib

Medicine

Lung cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!